ArticleMolecular cancer therapeutics2020

Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.

Sachin K Khiste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.